<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11859801</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1349</article-id><article-id pub-id-type="other">EPV0704</article-id><article-id pub-id-type="pii">S092493382401349X</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Fibromyalgia: functional, autoimmune or both? Treatment options for drug-resistant fibromyalgia</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Desport</surname><given-names>C. P.</given-names></name><xref rid="aff2999" ref-type="aff"/><xref rid="cor1200" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Martins</surname><given-names>D. O.</given-names></name><xref rid="aff2999" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Freitas</surname><given-names>J. R.</given-names></name><xref rid="aff2999" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>de Castro</surname><given-names>L. C.</given-names></name><xref rid="aff2999" ref-type="aff"/></contrib></contrib-group><aff id="aff2999">Psychiatry, <institution>Hospital de Magalh&#x000e3;es Lemos, Centro Hospitalar e Universit&#x000e1;rio do Porto</institution>, <city>Porto</city>, <country>Portugal</country></aff><author-notes><corresp id="cor1200"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1324">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S651</fpage><lpage>S651</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S092493382401349Xa.pdf"/><abstract><sec id="sec7214"><title>Introduction</title><p>fibromyalgia is a modern disease, with growing investigation concerning its etiology and treatment. It has become a very prevalent diagnosis and total remission of symptoms is the exception which is dramatic considering the socio-occupational impact of this highly debilitating disease.</p></sec><sec id="sec7215"><title>Objectives</title><p>to review the updates in the pathophysiology and treatment of fibromyalgia, especially when it is refractory to treatment. The authors also intend to better understand where fibromyalgia belongs, is it in psychiatry as a functional disorder or in rheumatology as an auto-immune disease?</p></sec><sec id="sec7216"><title>Methods</title><p>bibliographical search in PubMed database, using the key-words &#x0201c;fibromyalgia&#x0201d; and &#x0201c;psychiatry&#x0201d;, limited to works published in the last 10 years.</p></sec><sec id="sec7217"><title>Results</title><p>from our search resulted 158 articles, from reading of abstracts 30 were chosen for further reading.</p></sec><sec id="sec7218"><title>Conclusions</title><p>concerning the etiology of this disease, on the one hand psychological factors cannot be neglected since there are several studies finding a positive correlation between stressors like history of physical abuse and fibromyalgia in adulthood, on the other hand investigation and meta-analysis have found that the immune-inflammatory response system might be altered with dysregulation of pro and anti-inflammatory cytokines and cell-mediated immunity. Regarding treatment, symptom relief is often unsatisfactory with classical treatment and so adjunct treatment such as electrical neuromodulation and aerobic exercise might, respectively, be effective in reducing pain and depressive symptoms, thereby improving quality of life, and in improving fatigue and in a lesser degree sleep.</p></sec><sec id="sec7219"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>